Literature DB >> 10582762

The relation between antioxidant status and alterations in fatty acid profile in patients with Crohn disease and controls.

B J Geerling1, A C v Houwelingen, A Badart-Smook, R W Stockbrügger, R J Brummer.   

Abstract

BACKGROUND: A diminished antioxidant defence and alterations in the fatty acid profile may play a role in the pathophysiology of inflammation in Crohn disease (CD).
METHODS: Antioxidant status (serum antioxidant vitamins and minerals, glutathione peroxidase, and superoxide dismutase activity), disease activity, dietary intake, and the fatty acid profile in plasma and erythrocyte phospholipids were studied in patients with active CD (n = 12), inactive CD (n = 50), and controls (n = 70). Eight patients with active CD were re-evaluated during the subsequent phase of clinical remission. The relation between the variables was assessed by multiple linear regression.
RESULTS: We observed a significantly diminished antioxidant status in patients with active CD compared with inactive CD and controls. Furthermore, the antioxidant defence was depleted in patients with inactive CD compared with controls. An aberrant fatty acid profile in plasma phospholipids was found in active and inactive CD compared with controls. Multivariate analysis showed that the plasma phospholipid fatty acid indices were significantly associated with several antioxidants (beta-carotene, vitamin E, and glutathione peroxidase) in CD patients but not in controls.
CONCLUSION: The fatty acid profile in CD patients is significantly associated with disease activity and serum antioxidant concentrations. This observation, along with the diminished antioxidant defence in patients with active and inactive CD, indicates that antioxidants should be considered in the therapy of inflammation in CD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582762     DOI: 10.1080/003655299750024913

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Liquid diets for Crohn's disease.

Authors:  M O'Sullivan; C O'Morain
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Cholesterol metabolism in active Crohn's disease.

Authors:  Vladimír Hrabovský; Zdenek Zadák; Vladimír Bláha; Radomír Hyspler; Tomás Karlík; Arnost Martínek; Alice Mendlová
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?

Authors:  Ali Rezaie; Robyn D Parker; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

Review 4.  Concepts of oxidative stress and antioxidant defense in Crohn's disease.

Authors:  Mohammed A Alzoghaibi
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

5.  There Is a Differential Pattern in the Fatty Acid Profile in Children with CD Compared to Children with UC.

Authors:  Justyna Kikut; Arleta Drozd; Małgorzata Mokrzycka; Urszula Grzybowska-Chlebowczyk; Maciej Ziętek; Małgorzata Szczuko
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

6.  The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease.

Authors:  J Schwarz; M Vecka; F Stožický; R Pomahačová; B Staňková; E Tvrzická; M Kreslová; R Zahálková; J Sýkora
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

7.  Short-Chain and Total Fatty Acid Profile of Faeces or Plasma as Predictors of Food-Responsive Enteropathy in Dogs: A Preliminary Study.

Authors:  Cristina Higueras; Ana I Rey; Rosa Escudero; David Díaz-Regañón; Fernando Rodríguez-Franco; Mercedes García-Sancho; Beatriz Agulla; Angel Sainz
Journal:  Animals (Basel)       Date:  2021-12-31       Impact factor: 2.752

Review 8.  The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.

Authors:  Ioana Miruna Balmus; Alin Ciobica; Anca Trifan; Carol Stanciu
Journal:  Saudi J Gastroenterol       Date:  2016 Jan-Feb       Impact factor: 2.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.